Cargando…

Cariprazine alleviates core behavioral deficits in the prenatal valproic acid exposure model of autism spectrum disorder

RATIONALE: Autism spectrum disorder (ASD) is a neurodevelopmental condition characterized by deficits in social communication and interaction and restricted, repetitive behaviors. The unmet medical need in ASD is considerable since there is no approved pharmacotherapy for the treatment of these defi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Román, Viktor, Adham, Nika, Foley, Andrew G., Hanratty, Lynsey, Farkas, Bence, Lendvai, Balázs, Kiss, Béla
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2021
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8373751/ https://www.ncbi.nlm.nih.gov/pubmed/34264367 http://dx.doi.org/10.1007/s00213-021-05851-6

Ejemplares similares

The novel antipsychotic cariprazine stabilizes gamma oscillations in rat hippocampal slices
por: Meier, Maria A., et al.
Publicado: (2020)

Preclinical pharmacodynamic and pharmacokinetic characterization of the major metabolites of cariprazine
por: Kiss, Béla, et al.
Publicado: (2019)

The novel atypical antipsychotic cariprazine demonstrates dopamine D(2) receptor‐dependent partial agonist actions on rat mesencephalic dopamine neuronal activity
por: Delcourte, Sarah, et al.
Publicado: (2018)

The Effects of Cariprazine and Aripiprazole on PCP-Induced Deficits on Attention Assessed in the 5-Choice Serial Reaction Time Task
por: Barnes, Samuel A., et al.
Publicado: (2018)

Correction to: The Effects of Cariprazine and Aripiprazole on PCP-Induced Deficits on Attention Assessed in the 5-Choice Serial Reaction Time Task
por: Barnes, Samuel A., et al.
Publicado: (2018)

Preferential Effects of Cariprazine on Counteracting the Disruption of Social Interaction and Decrease in Extracellular Dopamine Levels Induced by the Dopamine D(3) Receptor Agonist, PD-128907 in Rats: Implications for the Treatment of Negative and Depressive Symptoms of Psychiatric Disorders
por: Kehr, Jan, et al.
Publicado: (2022)

Cariprazine Exhibits Anxiolytic and Dopamine D(3) Receptor-Dependent Antidepressant Effects in the Chronic Stress Model
por: Duric, Vanja, et al.
Publicado: (2017)

Cariprazine exerts antimanic properties and interferes with dopamine D(2) receptor β-arrestin interactions
por: Gao, Yonglin, et al.
Publicado: (2015)

Effects of cariprazine on extracellular levels of glutamate, GABA, dopamine, noradrenaline and serotonin in the medial prefrontal cortex in the rat phencyclidine model of schizophrenia studied by microdialysis and simultaneous recordings of locomotor activity
por: Kehr, Jan, et al.
Publicado: (2018)

Juvenile handling rescues autism-related effects of prenatal exposure to valproic acid
por: Seiffe, Araceli, et al.
Publicado: (2022)

Prenatal GABAB Receptor Agonist Administration Corrects the Inheritance of Autism-Like Core Behaviors in Offspring of Mice Prenatally Exposed to Valproic Acid
por: Jiang, Shucai, et al.
Publicado: (2022)

Cariprazine pharmacokinetics
Publicado: (2022)

Late onset deficits in synaptic plasticity in the valproic acid rat model of autism
por: Martin, Henry G. S., et al.
Publicado: (2014)

Sociability deficits after prenatal exposure to valproic acid are rescued by early social enrichment
por: Campolongo, Marcos, et al.
Publicado: (2018)

Prenatal valproic acid-induced autism marmoset model exhibits higher salivary cortisol levels
por: Nakamura, Madoka, et al.
Publicado: (2022)

Preferential binding to dopamine D(3) over D(2) receptors by cariprazine in patients with schizophrenia using PET with the D(3)/D(2) receptor ligand [(11)C]-(+)-PHNO
por: Girgis, Ragy R., et al.
Publicado: (2016)

Cariprazine hydrochloride for schizophrenia
Publicado: (2021)

Binding kinetics of cariprazine and aripiprazole at the dopamine D(3) receptor
por: Frank, Annika, et al.
Publicado: (2018)

Effects of an H3R Antagonist on the Animal Model of Autism Induced by Prenatal Exposure to Valproic Acid
por: Baronio, Diego, et al.
Publicado: (2015)

Neuronal Dopamine D3 Receptors: Translational Implications for Preclinical Research and CNS Disorders
por: Kiss, Béla, et al.
Publicado: (2021)

The GABAB receptor agonist STX209 reverses the autism-like behaviour in an animal model of autism induced by prenatal exposure to valproic acid
por: Jiang, Shucai, et al.
Publicado: (2022)

Alterations of the Hippocampal Networks in Valproic Acid-Induced Rat Autism Model
por: Bódi, Veronika, et al.
Publicado: (2022)

Suppression of NMDA receptor function in mice prenatally exposed to valproic acid improves social deficits and repetitive behaviors
por: Kang, Jaeseung, et al.
Publicado: (2015)

Transplantation of mesenchymal stem cells reverses behavioural deficits and impaired neurogenesis caused by prenatal exposure to valproic acid
por: Gobshtis, Nikolai, et al.
Publicado: (2017)

Oxytocin Differentiated Effects According to the Administration Route in a Prenatal Valproic Acid-Induced Rat Model of Autism
por: Lefter, Radu, et al.
Publicado: (2020)

Alterations in the autonomic nerve activities of prenatal autism model mice treated with valproic acid at different developmental stages
por: Kasahara, Yoshiyuki, et al.
Publicado: (2020)

Disrupted Social Hierarchy in Prenatally Valproate-Exposed Autistic-Like Rats
por: Pelsőczi, Péter, et al.
Publicado: (2020)

Cariprazine Safety in Adolescents and the Elderly: Analyses of Clinical Study Data
por: Szatmári, Balázs, et al.
Publicado: (2020)

Cariprazine in Pediatric Patients with Autism Spectrum Disorder: Results of a Pharmacokinetic, Safety and Tolerability Study
por: Yeung, Paul P., et al.
Publicado: (2023)

Minimal Effects of Cariprazine on Prolactin Levels in Bipolar Disorder and Schizophrenia
por: Culpepper, Larry, et al.
Publicado: (2022)

Improving Mood and Cognitive Symptoms in Huntington's Disease With Cariprazine Treatment
por: Molnar, Maria Judit, et al.
Publicado: (2022)

The improvement of motor symptoms in Huntington’s disease during cariprazine treatment
por: Csehi, Reka, et al.
Publicado: (2023)

Oral Supplementation with Maca Improves Social Recognition Deficits in the Valproic Acid Animal Model of Autism Spectrum Disorder
por: Fu, Pinyue, et al.
Publicado: (2023)

Reward-Related Behavioral, Neurochemical and Electrophysiological Changes in a Rat Model of Autism Based on Prenatal Exposure to Valproic Acid
por: Schiavi, Sara, et al.
Publicado: (2019)

Photobiomodulation Attenuated Cognitive Dysfunction and Neuroinflammation in a Prenatal Valproic Acid-Induced Autism Spectrum Disorder Mouse Model
por: Kim, Ui-Jin, et al.
Publicado: (2022)

Cariprazine: Patients with Treatment-Resistant Schizophrenia
por: Aubel, Thomas
Publicado: (2021)

Defining the therapeutic reference range for cariprazine
por: Kapás, M., et al.
Publicado: (2023)

Successful switching from risperidone to cariprazine in a schizophrenic patient with pronounced functional deficit. Case report
por: Sahlsten Schölin, Johan, et al.
Publicado: (2023)

Cariprazine in an Adolescent with Tourette Syndrome with Comorbid Attention Deficit Hyperactive Disorder and Depression: A Case Report
por: Gill, Jesjeet Singh
Publicado: (2023)

Canagliflozin alleviates valproic acid-induced autism in rat pups: Role of PTEN/PDK/PPAR-γ signaling pathways
por: Elgamal, Mariam A., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_liqs2sg1auigkemf5oaq8eg8r2